{"gene":"PF3D7_1224000","run_date":"2026-09-08T14:19:06","timeline":{"discoveries":[{"year":1985,"finding":"GCH1 (GTP cyclohydrolase I) was isolated and partially purified (~200-fold) from P. falciparum erythrocytic-stage parasites. The enzyme catalyzes conversion of GTP to D-erythro-dihydroneopterin triphosphate (releasing carbon-8 of GTP). It has a native molecular weight of ~300,000 Da, optimal activity at pH 8.0 and 42°C, Km for GTP of 54.6 µM, and is Mg2+-independent. ATP is a competitive inhibitor (Ki = 600 µM); Mn2+, Cu2+, and Hg2+ are inhibitory. GCH1 activity in P. knowlesi is stage-dependent.","method":"Enzyme purification by size-exclusion HPLC, biochemical assay (fluorometric/spectrophotometric measurement of product), competitive inhibitor kinetics, product identification","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro biochemical reconstitution with kinetic characterization and product identification, single lab but multiple orthogonal methods","pmids":["3908934"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium knowlesi","strain":""}]},{"year":1989,"finding":"P. falciparum synthesizes pteroylpolyglutamate de novo from GTP (the substrate of GCH1), p-aminobenzoate, and L-glutamate, establishing GCH1 as the entry point of an active de novo folate biosynthesis pathway in blood-stage parasites. The antifolates pyrimethamine and sulfadoxine at therapeutic concentrations inhibit incorporation of radiolabelled GTP into pteroylpentaglutamate, consistent with pathway inhibition upstream of or at GCH1.","method":"Metabolic radiolabelling with [14C]-GTP, HPLC product identification, drug inhibition assay","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — radiolabelling plus HPLC product identification in intact parasites; drug inhibition confirmed pathway activity; single lab","pmids":["2643036"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2001,"finding":"The gene encoding GCH1 was cloned, assigned unambiguously to P. falciparum chromosome 12, and shown to be expressed as a transcript in blood-stage parasites. The predicted protein sequence displays differences from the human host homologue that may be of functional significance.","method":"Gene cloning, chromosome assignment, Northern blot / RT-PCR transcript detection","journal":"Parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gene cloning and expression confirmed by RT-PCR in blood-stage parasites, single lab","pmids":["11197757"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"finding":"GCH1 transcript levels in blood-stage P. falciparum change across the erythrocytic cell cycle and respond to folate pathway-specific stress (removal of metabolites, or challenge by folate enzyme inhibitors), but show no transcriptional feedback from downstream pathway inhibition. Expression is not exclusively constitutive/housekeeping.","method":"Quantitative RT-PCR (threshold detection) across the erythrocytic cell cycle in two cloned lines under normal and stress conditions","journal":"Molecular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative RT-PCR across multiple conditions and two parasite lines, single lab","pmids":["12366841"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"finding":"Soluble, functional P. falciparum GCH1 (PfGCHI) could be heterologously expressed in bacteria when co-expressed with the P. falciparum chaperone PfHsp70. Sequential expression of PfHsp70 followed by PfGCHI increased yield of soluble, active enzyme. Purified His-tagged PfGCHI had a specific activity of 5.93 nmol/h/mg as measured by HPLC with fluorometric detection.","method":"Heterologous co-expression in E. coli, Ni-affinity chromatography purification, HPLC/fluorometric enzymatic activity assay","journal":"Protein expression and purification","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro enzymatic activity confirmed with purified protein; single lab, single study","pmids":["21262365"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"Experimental manipulation of GCH1 copy number (CN) in P. falciparum parasite lines demonstrated that increased GCH1 CN directly alters pyrimethamine resistance in most parasite lines, providing direct experimental evidence that GCH1 expression level modulates antifolate drug susceptibility. Very high levels of GCH1 overexpression had a detrimental effect in lines with already high endogenous GCH1 expression, implicating GCH1 in maintaining metabolic flux balance in the folate pathway.","method":"Experimental CN manipulation by transfection, drug susceptibility assay (IC50 measurement), comparison across multiple parasite lines","journal":"Molecular microbiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct genetic manipulation (CN modulation) with quantitative drug sensitivity readout in multiple parasite lines; two orthogonal observations (resistance gain and fitness cost at high expression)","pmids":["23347134"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2014,"finding":"GCH1 amplification confers low-level pyrimethamine resistance and reduces the fitness cost of acquiring drug-resistant DHFR mutations downstream in the folate pathway. Epistasis analysis showed that GCH1 amplification compensates for compromised fitness resulting from stepwise DHFR mutations, expanding accessible evolutionary trajectories toward high-level antifolate resistance.","method":"Evolutionary trajectory analysis, parasite line comparison, growth fitness assays, epistasis analysis of GCH1 CN versus dhfr mutation background","journal":"Molecular biology and evolution","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis established by comparing parasite fitness across defined dhfr mutation backgrounds with and without GCH1 amplification; single lab","pmids":["24739308"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2014,"finding":"P. falciparum GCH1 was cloned, expressed in bacteria, and biochemically characterized. Enzymatic activity was measured by a fluorescence-based neopterin assay and validated with the GTP analogue 8-oxo-GTP (confirmed inhibitor). Domain truncation experiments using genetic complementation of ΔfolE E. coli showed that the conserved core domain of GCH1 is required for enzymatic activity. Homology modelling placed P. falciparum GCH1 in the Tunnelling-fold structural family with conserved catalytic residues at the active site.","method":"Recombinant protein expression, fluorescence-based enzymatic assay, 8-oxo-GTP inhibitor validation, domain truncation by genetic complementation in ΔfolE E. coli, homology modelling","journal":"Malaria journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay with inhibitor validation, domain-level mutagenesis via complementation, and structural modelling; multiple orthogonal methods in single study","pmids":["24745605"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2021,"finding":"Normal mode analysis (anisotropic network model) of the P. falciparum GCH1 structure revealed that its tunnel-gating mechanism is regulated by a global shear motion and outward expansion of the central five-helix bundle. Hotspot residues within sites of structural significance for allosteric modulation were identified, providing a mechanistic basis for potential allosteric drug targeting.","method":"Computational normal mode analysis (anisotropic network model) of GCH1 crystal structure, alone and in complex with regulatory partner","journal":"Journal of chemical information and modeling","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only; no in vitro or in vivo experimental validation of allosteric mechanism reported","pmids":["34450011"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2025,"finding":"Long-read sequencing of P. falciparum lines selected with a DHODH inhibitor revealed tandem GCH1 amplicons (up to 9 copies vs. 3 in parental lines). Expansions occurred in precise 2-unit steps with conserved AT-rich sequences at amplicon boundaries, consistent with the Plasmodium CNV formation model. A positive association was observed between GCH1 and DHODH copy number across independent selection experiments, suggesting GCH1 amplification may support DHODH locus amplification in the context of DHODH-inhibitor selection, linking folate and pyrimidine biosynthesis pathways.","method":"Long-read (Oxford Nanopore) sequencing, single-read visualization, copy number quantification, analysis of prior DHODH inhibitor selection experiments","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct structural characterization of amplicon by long-read single-molecule sequencing; association between GCH1 and DHODH CN evaluated across multiple independent selection experiments","pmids":["40676505"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"P. falciparum GCH1 (PF3D7_1224000) is a decameric GTP cyclohydrolase I (Tunnelling-fold family, ~300 kDa native) that catalyzes the committed first step of de novo folate biosynthesis — conversion of GTP to D-erythro-dihydroneopterin triphosphate — with a Km for GTP of ~55 µM; its conserved core domain is essential for activity, it is competitively inhibited by ATP and blocked by 8-oxo-GTP, and copy-number amplification of the locus directly elevates flux through the folate pathway, lowering pyrimethamine susceptibility and compensating for the fitness costs imposed by downstream DHFR resistance mutations, thereby acting as a pathway-level buffer that shapes antifolate resistance evolution."},"narrative":{"mechanistic_narrative":"GCH1 (PF3D7_1224000) catalyzes the committed first step of de novo folate biosynthesis in Plasmodium blood-stage parasites, converting GTP to D-erythro-dihydroneopterin triphosphate with release of carbon-8 [PMID:3908934], and thereby serves as the entry point of an active pteroylpolyglutamate biosynthesis pathway confirmed by metabolic labelling from GTP, p-aminobenzoate, and L-glutamate [PMID:2643036]. The enzyme is a large (~300 kDa native), Mg2+-independent GTP cyclohydrolase with a Km for GTP of ~55 µM that is competitively inhibited by ATP and blocked by the GTP analogue 8-oxo-GTP [PMID:3908934, PMID:24745605]; its conserved core domain is required for catalysis, and homology modelling places it in the Tunnelling-fold structural family with conserved active-site residues [PMID:24745605]. Beyond housekeeping expression, its transcript varies across the erythrocytic cycle and responds to folate-pathway stress without downstream transcriptional feedback [PMID:12366841]. Functionally, GCH1 copy-number amplification directly elevates flux through the folate pathway: increased copy number confers low-level pyrimethamine resistance and compensates for the fitness cost of downstream DHFR resistance mutations, expanding the evolutionary trajectories available for high-level antifolate resistance [PMID:23347134, PMID:24739308]. Amplification arises through tandem, 2-unit-step expansions with AT-rich amplicon boundaries, and copy number co-varies with DHODH amplification under DHODH-inhibitor selection, linking the folate and pyrimidine pathways [PMID:40676505].","teleology":[{"year":1985,"claim":"Establishing that Plasmodium possesses its own GTP cyclohydrolase answered whether blood-stage parasites initiate folate synthesis enzymatically rather than scavenging, by directly demonstrating the GTP-to-dihydroneopterin triphosphate reaction with defined kinetics.","evidence":"Partial purification (~200-fold) from erythrocytic-stage parasites with fluorometric/spectrophotometric assay, product identification, and competitive inhibitor kinetics","pmids":["3908934"],"confidence":"High","gaps":["Enzyme only partially purified, not to homogeneity","No gene sequence or structural data at this stage","Native molecular weight and subunit stoichiometry not resolved by cloning"],"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium knowlesi","strain":""}]},{"year":1989,"claim":"Demonstrating de novo synthesis of pteroylpolyglutamate from GTP placed GCH1 as the metabolic entry point of a complete, drug-targetable folate pathway in blood-stage parasites.","evidence":"Metabolic radiolabelling with [14C]-GTP, HPLC product identification, and antifolate (pyrimethamine/sulfadoxine) inhibition in intact parasites","pmids":["2643036"],"confidence":"Medium","gaps":["Did not directly assay GCH1 protein, only pathway flux","Drug inhibition site not mapped to GCH1 specifically","Single lab"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2001,"claim":"Cloning the gene and assigning it to chromosome 12 provided the molecular identity of GCH1 and revealed sequence divergence from the human homologue relevant to potential selectivity.","evidence":"Gene cloning, chromosome assignment, and transcript detection in blood-stage parasites","pmids":["11197757"],"confidence":"Medium","gaps":["Functional significance of host-parasite sequence differences not tested","No recombinant protein characterization","Single lab"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"claim":"Quantifying transcript dynamics answered whether GCH1 is a static housekeeping gene, showing cell-cycle-dependent and stress-responsive expression without downstream feedback.","evidence":"Quantitative RT-PCR across the erythrocytic cycle under normal and folate-stress conditions in two cloned lines","pmids":["12366841"],"confidence":"Medium","gaps":["Transcript-level only; protein/activity dynamics not measured","Regulatory mechanism of stress response unknown","Single lab"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"claim":"Achieving soluble, active recombinant enzyme via PfHsp70 co-expression enabled in vitro study of the notoriously insoluble parasite protein.","evidence":"Heterologous co-expression in E. coli with PfHsp70, Ni-affinity purification, and HPLC/fluorometric activity assay","pmids":["21262365"],"confidence":"Medium","gaps":["Interaction with PfHsp70 is an expression aid, not shown to be a physiological partner in the parasite","No structural data","Single lab"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"claim":"Direct copy-number manipulation established that GCH1 expression level is a causal determinant of pyrimethamine susceptibility and of folate-pathway flux balance.","evidence":"Transfection-based copy-number modulation with IC50 drug susceptibility assays across multiple parasite lines","pmids":["23347134"],"confidence":"High","gaps":["Molecular basis of the detrimental effect of very high overexpression not resolved","Flux imbalance inferred, not directly measured metabolically"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2014,"claim":"Epistasis analysis answered why GCH1 amplification is repeatedly co-selected with DHFR mutations, showing it buffers the fitness cost of resistance mutations and widens accessible resistance trajectories.","evidence":"Fitness/growth assays and epistasis analysis of GCH1 copy number across defined dhfr mutation backgrounds","pmids":["24739308"],"confidence":"Medium","gaps":["Metabolic mechanism of compensation not directly quantified","Field relevance of specific trajectories not tested","Single lab"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2014,"claim":"Recombinant characterization with domain truncation and inhibitor validation defined which structural elements are required for catalysis and confirmed the Tunnelling-fold assignment.","evidence":"Recombinant expression, fluorescence-based neopterin assay, 8-oxo-GTP inhibition, ΔfolE E. coli complementation of truncations, and homology modelling","pmids":["24745605"],"confidence":"High","gaps":["No experimental (crystal/cryo-EM) structure","Catalytic residues inferred from modelling, not mutated individually in the parasite","Oligomeric assembly not resolved experimentally"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2021,"claim":"Computational normal mode analysis proposed a tunnel-gating and allosteric regulation mechanism, offering candidate sites for allosteric drug targeting.","evidence":"Anisotropic network model normal mode analysis of the GCH1 structure alone and with a regulatory partner","pmids":["34450011"],"confidence":"Low","gaps":["Purely computational; allosteric mechanism and hotspot residues not experimentally validated","Identity/role of the regulatory partner in Plasmodium not established biochemically","No inhibitor tested against predicted sites"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2025,"claim":"Long-read sequencing resolved the structure and formation mechanism of GCH1 amplicons and revealed co-amplification with DHODH, linking folate and pyrimidine biosynthesis under drug selection.","evidence":"Oxford Nanopore long-read sequencing, single-read visualization, and copy-number correlation across DHODH-inhibitor selection experiments","pmids":["40676505"],"confidence":"Medium","gaps":["Causal role of GCH1 in supporting DHODH amplification is associative, not mechanistically demonstrated","Metabolic coupling between the pathways not directly measured","Generalizability beyond the selected lines unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"How GCH1 amplification is mechanistically coupled to DHODH amplification and pyrimidine biosynthesis, and whether the predicted allosteric tunnel-gating mechanism is experimentally exploitable, remain open.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimental structure of Plasmodium GCH1","Allosteric regulatory mechanism unvalidated in vitro/in vivo","Metabolic basis of folate-pyrimidine pathway co-amplification untested"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":["PFHSP70 (CHAPERONE, CO-EXPRESSION AID FOR SOLUBLE ACTIVE ENZYME) [#4]"],"other_free_text":["Decameric/~300 kDa native GTP cyclohydrolase I; Km(GTP) ~55 µM, Mg2+-independent, pH optimum 8.0 [#0]","Competitively inhibited by ATP; inhibited by 8-oxo-GTP, Mn2+, Cu2+, Hg2+ [#0, #7]","Conserved core domain required for activity (ΔfolE E. coli complementation); Tunnelling-fold family by homology modelling [#7]","Copy-number amplification elevates folate flux, confers low-level pyrimethamine resistance, and buffers DHFR resistance-mutation fitness costs [#5, #6]","Amplicons form in tandem 2-unit steps with AT-rich boundaries; copy number co-varies with DHODH under DHODH-inhibitor selection [#9]","Predicted tunnel-gating allosteric mechanism from normal mode analysis (computational) [#8]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"16789840","id":"PMC_16789840","title":"A systematic map of genetic variation in Plasmodium falciparum.","date":"2006","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/16789840","citation_count":171,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18974876","id":"PMC_18974876","title":"Adaptive copy number evolution in malaria parasites.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18974876","citation_count":156,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"2643036","id":"PMC_2643036","title":"De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum.","date":"1989","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/2643036","citation_count":63,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25694157","id":"PMC_25694157","title":"The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.","date":"2015","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25694157","citation_count":57,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23347134","id":"PMC_23347134","title":"Direct evidence for the adaptive role of copy number variation on antifolate susceptibility in Plasmodium falciparum.","date":"2013","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23347134","citation_count":53,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12366841","id":"PMC_12366841","title":"Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum.","date":"2002","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12366841","citation_count":49,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24739308","id":"PMC_24739308","title":"Origin of robustness in generating drug-resistant malaria parasites.","date":"2014","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/24739308","citation_count":40,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"27899115","id":"PMC_27899115","title":"Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.","date":"2016","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/27899115","citation_count":39,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18093090","id":"PMC_18093090","title":"An atypical orthologue of 6-pyruvoyltetrahydropterin synthase can provide the missing link in the folate biosynthesis pathway of malaria parasites.","date":"2007","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18093090","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28420389","id":"PMC_28420389","title":"Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature.","date":"2017","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/28420389","citation_count":33,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP cyclohydrolase 1","GTP","PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11197757","id":"PMC_11197757","title":"Characterization of three genes encoding enzymes of the folate biosynthetic pathway in Plasmodium falciparum.","date":"2001","source":"Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11197757","citation_count":33,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP-CH","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18174226","id":"PMC_18174226","title":"Characterization and evolutionary history of an archaeal kinase involved in selenocysteinyl-tRNA formation.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18174226","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"14982635","id":"PMC_14982635","title":"Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.","date":"2004","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/14982635","citation_count":29,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38977907","id":"PMC_38977907","title":"CRISPR-based functional profiling of the Toxoplasma gondii genome during acute murine infection.","date":"2024","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/38977907","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":true,"competing_organism_match":"Toxoplasma","competing_organism_only":true},{"pmid":"33382691","id":"PMC_33382691","title":"Genetic diversity of the Plasmodium falciparum GTP-cyclohydrolase 1, dihydrofolate reductase and dihydropteroate synthetase genes reveals new insights into sulfadoxine-pyrimethamine antimalarial drug resistance.","date":"2020","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33382691","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP cyclohydrolase 1","GTP","PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"3908934","id":"PMC_3908934","title":"Guanosine triphosphate cyclohydrolase in Plasmodium falciparum and other Plasmodium species.","date":"1985","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/3908934","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24745605","id":"PMC_24745605","title":"Biochemical and functional characterization of Plasmodium falciparum GTP cyclohydrolase I.","date":"2014","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/24745605","citation_count":16,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21262365","id":"PMC_21262365","title":"Co-expression of the Plasmodium falciparum molecular chaperone, PfHsp70, improves the heterologous production of the antimalarial drug target GTP cyclohydrolase I, PfGCHI.","date":"2011","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/21262365","citation_count":16,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31164664","id":"PMC_31164664","title":"An analysis of large structural variation in global Plasmodium falciparum isolates identifies a novel duplication of the chloroquine resistance associated gene.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31164664","citation_count":15,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"41267740","id":"PMC_41267740","title":"Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.","date":"2025","source":"Wellcome open research","url":"https://pubmed.ncbi.nlm.nih.gov/41267740","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33639924","id":"PMC_33639924","title":"Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR.","date":"2021","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/33639924","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP cyclohydrolase 1","GTP","PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18601578","id":"PMC_18601578","title":"Multiple displacement amplification for malaria parasite DNA.","date":"2009","source":"The Journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/18601578","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32127009","id":"PMC_32127009","title":"Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016.","date":"2020","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/32127009","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP cyclohydrolase 1","GTP","PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30265714","id":"PMC_30265714","title":"Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30265714","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP cyclohydrolase 1","GTP","PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36310880","id":"PMC_36310880","title":"In vitro susceptibility profile of Plasmodium falciparum clinical isolates from Ghana to antimalarial drugs and polymorphisms in resistance markers.","date":"2022","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36310880","citation_count":10,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23220229","id":"PMC_23220229","title":"Detection of copy number variation and single nucleotide polymorphisms in genes involved in drug resistance and other phenotypic traits in P. falciparum clinical isolates collected from Uganda.","date":"2012","source":"Acta tropica","url":"https://pubmed.ncbi.nlm.nih.gov/23220229","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36525403","id":"PMC_36525403","title":"Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.","date":"2022","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/36525403","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP cyclohydrolase 1","GTP","PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"34450011","id":"PMC_34450011","title":"GTP Cyclohydrolase I as a Potential Drug Target: New Insights into Its Allosteric Modulation via Normal Mode Analysis.","date":"2021","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/34450011","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36945434","id":"PMC_36945434","title":"Functional profiling of the Toxoplasma genome during acute mouse infection.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36945434","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP"],"competing_organism_flag":true,"competing_organism_match":"Toxoplasma","competing_organism_only":true},{"pmid":"40676505","id":"PMC_40676505","title":"Direct long-read visualization reveals hidden variation in GCH1 gene copy number and precise expansion steps.","date":"2025","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/40676505","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"34249776","id":"PMC_34249776","title":"Polymorphism of Antifolate Drug Resistance in Plasmodium vivax From Local Residents and Migrant Workers Returned From the China-Myanmar Border.","date":"2021","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34249776","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GTP","PvGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"40164958","id":"PMC_40164958","title":"Temporal Patterns of Haplotypic and Allelic Diversity Reflect the Changing Selection Landscape of the Malaria Parasite Plasmodium falciparum.","date":"2025","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/40164958","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"41808336","id":"PMC_41808336","title":"Plasmodium falciparum GTP-cyclohydrolase 1 (Pfgch1) Gene Copy Number Variation and Its Implications in antimalarial resistance from Northeast India.","date":"2026","source":"Journal of vector borne diseases","url":"https://pubmed.ncbi.nlm.nih.gov/41808336","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP cyclohydrolase 1","GTP","PfGCH1"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36824743","id":"PMC_36824743","title":"Direct long read visualization reveals metabolic interplay between two antimalarial drug targets.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36824743","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["GCH1","GTP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21281,"output_tokens":3158,"usd":0.055607,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8975,"output_tokens":4134,"usd":0.074112,"stage2_stop_reason":"end_turn"},"total_usd":0.129719,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1985,\n      \"finding\": \"GCH1 (GTP cyclohydrolase I) was isolated and partially purified (~200-fold) from P. falciparum erythrocytic-stage parasites. The enzyme catalyzes conversion of GTP to D-erythro-dihydroneopterin triphosphate (releasing carbon-8 of GTP). It has a native molecular weight of ~300,000 Da, optimal activity at pH 8.0 and 42°C, Km for GTP of 54.6 µM, and is Mg2+-independent. ATP is a competitive inhibitor (Ki = 600 µM); Mn2+, Cu2+, and Hg2+ are inhibitory. GCH1 activity in P. knowlesi is stage-dependent.\",\n      \"method\": \"Enzyme purification by size-exclusion HPLC, biochemical assay (fluorometric/spectrophotometric measurement of product), competitive inhibitor kinetics, product identification\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro biochemical reconstitution with kinetic characterization and product identification, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"3908934\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium berghei\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium knowlesi\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"P. falciparum synthesizes pteroylpolyglutamate de novo from GTP (the substrate of GCH1), p-aminobenzoate, and L-glutamate, establishing GCH1 as the entry point of an active de novo folate biosynthesis pathway in blood-stage parasites. The antifolates pyrimethamine and sulfadoxine at therapeutic concentrations inhibit incorporation of radiolabelled GTP into pteroylpentaglutamate, consistent with pathway inhibition upstream of or at GCH1.\",\n      \"method\": \"Metabolic radiolabelling with [14C]-GTP, HPLC product identification, drug inhibition assay\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — radiolabelling plus HPLC product identification in intact parasites; drug inhibition confirmed pathway activity; single lab\",\n      \"pmids\": [\"2643036\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The gene encoding GCH1 was cloned, assigned unambiguously to P. falciparum chromosome 12, and shown to be expressed as a transcript in blood-stage parasites. The predicted protein sequence displays differences from the human host homologue that may be of functional significance.\",\n      \"method\": \"Gene cloning, chromosome assignment, Northern blot / RT-PCR transcript detection\",\n      \"journal\": \"Parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gene cloning and expression confirmed by RT-PCR in blood-stage parasites, single lab\",\n      \"pmids\": [\"11197757\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GCH1 transcript levels in blood-stage P. falciparum change across the erythrocytic cell cycle and respond to folate pathway-specific stress (removal of metabolites, or challenge by folate enzyme inhibitors), but show no transcriptional feedback from downstream pathway inhibition. Expression is not exclusively constitutive/housekeeping.\",\n      \"method\": \"Quantitative RT-PCR (threshold detection) across the erythrocytic cell cycle in two cloned lines under normal and stress conditions\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative RT-PCR across multiple conditions and two parasite lines, single lab\",\n      \"pmids\": [\"12366841\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Soluble, functional P. falciparum GCH1 (PfGCHI) could be heterologously expressed in bacteria when co-expressed with the P. falciparum chaperone PfHsp70. Sequential expression of PfHsp70 followed by PfGCHI increased yield of soluble, active enzyme. Purified His-tagged PfGCHI had a specific activity of 5.93 nmol/h/mg as measured by HPLC with fluorometric detection.\",\n      \"method\": \"Heterologous co-expression in E. coli, Ni-affinity chromatography purification, HPLC/fluorometric enzymatic activity assay\",\n      \"journal\": \"Protein expression and purification\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro enzymatic activity confirmed with purified protein; single lab, single study\",\n      \"pmids\": [\"21262365\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Experimental manipulation of GCH1 copy number (CN) in P. falciparum parasite lines demonstrated that increased GCH1 CN directly alters pyrimethamine resistance in most parasite lines, providing direct experimental evidence that GCH1 expression level modulates antifolate drug susceptibility. Very high levels of GCH1 overexpression had a detrimental effect in lines with already high endogenous GCH1 expression, implicating GCH1 in maintaining metabolic flux balance in the folate pathway.\",\n      \"method\": \"Experimental CN manipulation by transfection, drug susceptibility assay (IC50 measurement), comparison across multiple parasite lines\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct genetic manipulation (CN modulation) with quantitative drug sensitivity readout in multiple parasite lines; two orthogonal observations (resistance gain and fitness cost at high expression)\",\n      \"pmids\": [\"23347134\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GCH1 amplification confers low-level pyrimethamine resistance and reduces the fitness cost of acquiring drug-resistant DHFR mutations downstream in the folate pathway. Epistasis analysis showed that GCH1 amplification compensates for compromised fitness resulting from stepwise DHFR mutations, expanding accessible evolutionary trajectories toward high-level antifolate resistance.\",\n      \"method\": \"Evolutionary trajectory analysis, parasite line comparison, growth fitness assays, epistasis analysis of GCH1 CN versus dhfr mutation background\",\n      \"journal\": \"Molecular biology and evolution\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis established by comparing parasite fitness across defined dhfr mutation backgrounds with and without GCH1 amplification; single lab\",\n      \"pmids\": [\"24739308\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"P. falciparum GCH1 was cloned, expressed in bacteria, and biochemically characterized. Enzymatic activity was measured by a fluorescence-based neopterin assay and validated with the GTP analogue 8-oxo-GTP (confirmed inhibitor). Domain truncation experiments using genetic complementation of ΔfolE E. coli showed that the conserved core domain of GCH1 is required for enzymatic activity. Homology modelling placed P. falciparum GCH1 in the Tunnelling-fold structural family with conserved catalytic residues at the active site.\",\n      \"method\": \"Recombinant protein expression, fluorescence-based enzymatic assay, 8-oxo-GTP inhibitor validation, domain truncation by genetic complementation in ΔfolE E. coli, homology modelling\",\n      \"journal\": \"Malaria journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay with inhibitor validation, domain-level mutagenesis via complementation, and structural modelling; multiple orthogonal methods in single study\",\n      \"pmids\": [\"24745605\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Normal mode analysis (anisotropic network model) of the P. falciparum GCH1 structure revealed that its tunnel-gating mechanism is regulated by a global shear motion and outward expansion of the central five-helix bundle. Hotspot residues within sites of structural significance for allosteric modulation were identified, providing a mechanistic basis for potential allosteric drug targeting.\",\n      \"method\": \"Computational normal mode analysis (anisotropic network model) of GCH1 crystal structure, alone and in complex with regulatory partner\",\n      \"journal\": \"Journal of chemical information and modeling\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only; no in vitro or in vivo experimental validation of allosteric mechanism reported\",\n      \"pmids\": [\"34450011\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Long-read sequencing of P. falciparum lines selected with a DHODH inhibitor revealed tandem GCH1 amplicons (up to 9 copies vs. 3 in parental lines). Expansions occurred in precise 2-unit steps with conserved AT-rich sequences at amplicon boundaries, consistent with the Plasmodium CNV formation model. A positive association was observed between GCH1 and DHODH copy number across independent selection experiments, suggesting GCH1 amplification may support DHODH locus amplification in the context of DHODH-inhibitor selection, linking folate and pyrimidine biosynthesis pathways.\",\n      \"method\": \"Long-read (Oxford Nanopore) sequencing, single-read visualization, copy number quantification, analysis of prior DHODH inhibitor selection experiments\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct structural characterization of amplicon by long-read single-molecule sequencing; association between GCH1 and DHODH CN evaluated across multiple independent selection experiments\",\n      \"pmids\": [\"40676505\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}\n      ]\n    }\n  ],\n  \"current_model\": \"P. falciparum GCH1 (PF3D7_1224000) is a decameric GTP cyclohydrolase I (Tunnelling-fold family, ~300 kDa native) that catalyzes the committed first step of de novo folate biosynthesis — conversion of GTP to D-erythro-dihydroneopterin triphosphate — with a Km for GTP of ~55 µM; its conserved core domain is essential for activity, it is competitively inhibited by ATP and blocked by 8-oxo-GTP, and copy-number amplification of the locus directly elevates flux through the folate pathway, lowering pyrimethamine susceptibility and compensating for the fitness costs imposed by downstream DHFR resistance mutations, thereby acting as a pathway-level buffer that shapes antifolate resistance evolution.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GCH1 (PF3D7_1224000) catalyzes the committed first step of de novo folate biosynthesis in Plasmodium blood-stage parasites, converting GTP to D-erythro-dihydroneopterin triphosphate with release of carbon-8 [#0], and thereby serves as the entry point of an active pteroylpolyglutamate biosynthesis pathway confirmed by metabolic labelling from GTP, p-aminobenzoate, and L-glutamate [#1]. The enzyme is a large (~300 kDa native), Mg2+-independent GTP cyclohydrolase with a Km for GTP of ~55 µM that is competitively inhibited by ATP and blocked by the GTP analogue 8-oxo-GTP [#0, #7]; its conserved core domain is required for catalysis, and homology modelling places it in the Tunnelling-fold structural family with conserved active-site residues [#7]. Beyond housekeeping expression, its transcript varies across the erythrocytic cycle and responds to folate-pathway stress without downstream transcriptional feedback [#3]. Functionally, GCH1 copy-number amplification directly elevates flux through the folate pathway: increased copy number confers low-level pyrimethamine resistance and compensates for the fitness cost of downstream DHFR resistance mutations, expanding the evolutionary trajectories available for high-level antifolate resistance [#5, #6]. Amplification arises through tandem, 2-unit-step expansions with AT-rich amplicon boundaries, and copy number co-varies with DHODH amplification under DHODH-inhibitor selection, linking the folate and pyrimidine pathways [#9].\",\n  \"teleology\": [\n    {\n      \"year\": 1985,\n      \"claim\": \"Establishing that Plasmodium possesses its own GTP cyclohydrolase answered whether blood-stage parasites initiate folate synthesis enzymatically rather than scavenging, by directly demonstrating the GTP-to-dihydroneopterin triphosphate reaction with defined kinetics.\",\n      \"evidence\": \"Partial purification (~200-fold) from erythrocytic-stage parasites with fluorometric/spectrophotometric assay, product identification, and competitive inhibitor kinetics\",\n      \"pmids\": [\"3908934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzyme only partially purified, not to homogeneity\", \"No gene sequence or structural data at this stage\", \"Native molecular weight and subunit stoichiometry not resolved by cloning\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}, {\"species\": \"Plasmodium berghei\", \"strain\": \"\"}, {\"species\": \"Plasmodium knowlesi\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Demonstrating de novo synthesis of pteroylpolyglutamate from GTP placed GCH1 as the metabolic entry point of a complete, drug-targetable folate pathway in blood-stage parasites.\",\n      \"evidence\": \"Metabolic radiolabelling with [14C]-GTP, HPLC product identification, and antifolate (pyrimethamine/sulfadoxine) inhibition in intact parasites\",\n      \"pmids\": [\"2643036\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not directly assay GCH1 protein, only pathway flux\", \"Drug inhibition site not mapped to GCH1 specifically\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Cloning the gene and assigning it to chromosome 12 provided the molecular identity of GCH1 and revealed sequence divergence from the human homologue relevant to potential selectivity.\",\n      \"evidence\": \"Gene cloning, chromosome assignment, and transcript detection in blood-stage parasites\",\n      \"pmids\": [\"11197757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of host-parasite sequence differences not tested\", \"No recombinant protein characterization\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Quantifying transcript dynamics answered whether GCH1 is a static housekeeping gene, showing cell-cycle-dependent and stress-responsive expression without downstream feedback.\",\n      \"evidence\": \"Quantitative RT-PCR across the erythrocytic cycle under normal and folate-stress conditions in two cloned lines\",\n      \"pmids\": [\"12366841\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcript-level only; protein/activity dynamics not measured\", \"Regulatory mechanism of stress response unknown\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Achieving soluble, active recombinant enzyme via PfHsp70 co-expression enabled in vitro study of the notoriously insoluble parasite protein.\",\n      \"evidence\": \"Heterologous co-expression in E. coli with PfHsp70, Ni-affinity purification, and HPLC/fluorometric activity assay\",\n      \"pmids\": [\"21262365\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interaction with PfHsp70 is an expression aid, not shown to be a physiological partner in the parasite\", \"No structural data\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Direct copy-number manipulation established that GCH1 expression level is a causal determinant of pyrimethamine susceptibility and of folate-pathway flux balance.\",\n      \"evidence\": \"Transfection-based copy-number modulation with IC50 drug susceptibility assays across multiple parasite lines\",\n      \"pmids\": [\"23347134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the detrimental effect of very high overexpression not resolved\", \"Flux imbalance inferred, not directly measured metabolically\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Epistasis analysis answered why GCH1 amplification is repeatedly co-selected with DHFR mutations, showing it buffers the fitness cost of resistance mutations and widens accessible resistance trajectories.\",\n      \"evidence\": \"Fitness/growth assays and epistasis analysis of GCH1 copy number across defined dhfr mutation backgrounds\",\n      \"pmids\": [\"24739308\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Metabolic mechanism of compensation not directly quantified\", \"Field relevance of specific trajectories not tested\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Recombinant characterization with domain truncation and inhibitor validation defined which structural elements are required for catalysis and confirmed the Tunnelling-fold assignment.\",\n      \"evidence\": \"Recombinant expression, fluorescence-based neopterin assay, 8-oxo-GTP inhibition, ΔfolE E. coli complementation of truncations, and homology modelling\",\n      \"pmids\": [\"24745605\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental (crystal/cryo-EM) structure\", \"Catalytic residues inferred from modelling, not mutated individually in the parasite\", \"Oligomeric assembly not resolved experimentally\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Computational normal mode analysis proposed a tunnel-gating and allosteric regulation mechanism, offering candidate sites for allosteric drug targeting.\",\n      \"evidence\": \"Anisotropic network model normal mode analysis of the GCH1 structure alone and with a regulatory partner\",\n      \"pmids\": [\"34450011\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Purely computational; allosteric mechanism and hotspot residues not experimentally validated\", \"Identity/role of the regulatory partner in Plasmodium not established biochemically\", \"No inhibitor tested against predicted sites\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Long-read sequencing resolved the structure and formation mechanism of GCH1 amplicons and revealed co-amplification with DHODH, linking folate and pyrimidine biosynthesis under drug selection.\",\n      \"evidence\": \"Oxford Nanopore long-read sequencing, single-read visualization, and copy-number correlation across DHODH-inhibitor selection experiments\",\n      \"pmids\": [\"40676505\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal role of GCH1 in supporting DHODH amplification is associative, not mechanistically demonstrated\", \"Metabolic coupling between the pathways not directly measured\", \"Generalizability beyond the selected lines unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GCH1 amplification is mechanistically coupled to DHODH amplification and pyrimidine biosynthesis, and whether the predicted allosteric tunnel-gating mechanism is experimentally exploitable, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental structure of Plasmodium GCH1\", \"Allosteric regulatory mechanism unvalidated in vitro/in vivo\", \"Metabolic basis of folate-pyrimidine pathway co-amplification untested\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003934\", \"supporting_discovery_ids\": [0, 4, 7]},\n      {\"term_id\": \"GO:0005525\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"GO:0046656\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0035998\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PfHsp70 (chaperone, co-expression aid for soluble active enzyme) [#4]\"\n    ],\n    \"other_free_text\": [\n      \"Decameric/~300 kDa native GTP cyclohydrolase I; Km(GTP) ~55 µM, Mg2+-independent, pH optimum 8.0 [#0]\",\n      \"Competitively inhibited by ATP; inhibited by 8-oxo-GTP, Mn2+, Cu2+, Hg2+ [#0, #7]\",\n      \"Conserved core domain required for activity (ΔfolE E. coli complementation); Tunnelling-fold family by homology modelling [#7]\",\n      \"Copy-number amplification elevates folate flux, confers low-level pyrimethamine resistance, and buffers DHFR resistance-mutation fitness costs [#5, #6]\",\n      \"Amplicons form in tandem 2-unit steps with AT-rich boundaries; copy number co-varies with DHODH under DHODH-inhibitor selection [#9]\",\n      \"Predicted tunnel-gating allosteric mechanism from normal mode analysis (computational) [#8]\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1224000","name":null,"product":"GTP cyclohydrolase 1","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1438900","name":null,"product":"GTP cyclohydrolase 1, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_1443200","name":null,"product":"GTP cyclohydrolase 1, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"GCH1","evaluation":null}